Latest News & Updates
Breaking News
1 hour ago
Simantini Singh Deo
Other trending news you may like to read
Abeona Therapeutics Inc. Expands Access To ZEVASKYN As NewYork-Presbyterian/Columbia University Irving Medical Center Becomes Latest Qualified Treatment Center
Abeona Therapeutics expands ZEVASKYN access with new Qualified Treatment Center in New York, supporting gene therapy delivery for epidermolysis bullosa patients
Simantini Singh Deo
Annovis Bio Receives New U.S. Patent For Buntanetap To Prevent And Treat Brain Injuries Caused By Infections
Annovis Bio secures U.S. patent for buntanetap to prevent and treat infection-related brain injuries, expanding its neurodegenerative therapy program in Phase 3 development
Simantini Singh Deo
BioCardia, Inc. Submits CardiAMP HF Clinical Data To U.S. Food And Drug Administration To Pursue Potential Accelerated Approval Pathway
BioCardia submits CardiAMP HF clinical data to FDA to pursue accelerated approval pathway for its cell therapy in ischemic heart failure patients with reduced ejection fraction
Simantini Singh Deo
Biodexa Pharmaceuticals PLC Partners With Syngene International Ltd To Manufacture MTX240 API And Finished Dosage Form
Biodexa Pharmaceuticals partners with Syngene International to manufacture MTX240 API and dosage form, supporting IND filing and Phase 1b/2a trial in GIST cancer
Simantini Singh Deo
